A
Akeso Biopharma
Biotech & Life Sciences · Zhongshan, China · Founded 2012 · IPO 2020 Decacorn
Investors
4 investors on Akeso Biopharma's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Akeso Biopharma has talent and traffic
(1 of 112 staff)
across markets
Patent intelligence
$59M patent portfolio · 102 active families
Where Akeso Biopharma concentrates vs peers
Each axis is a top-10 topic across Akeso Biopharma and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Akeso Biopharma's 1 investments and acquisitions.
Every disclosed deal where Akeso Biopharma appeared as a backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
1 deals across Akeso Biopharma's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Akeso Biopharma deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Akeso Biopharma's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Akeso Biopharma
An AI-synthesized read of the highest-engagement posts about Akeso Biopharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Akeso Biopharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.